Maternal immune activation (MIA) contributes to behavioural abnormalities associated with neurodevelopmental disorders in both primate and rodent offspring [1] [2] [3][4] . In humans, epidemiological studies suggest that exposure of fetuses to maternal inflammation increases the likelihood of developing autism spectrum disorder [5] [6] [7] . In pregnant mice, interleukin-17a (IL-17a) produced by T helper 17 (T H 17) cells (CD4 + T helper effector cells involved in multiple inflammatory conditions) induces behavioural and cortical abnormalities in the offspring exposed to MIA 8 . However, it is unclear whether other maternal factors are required to promote MIA-associated phenotypes. Moreover, the underlying mechanisms by which MIA leads to T cell activation with increased IL-17a in the maternal circulation are not well understood. Here we show that MIA phenotypes in offspring require maternal intestinal bacteria that promote T H 17 cell differentiation. Pregnant mice that had been colonized with mouse commensal segmented filamentous bacteria or human commensal bacteria that induce intestinal T H 17 cells were more likely to produce offspring with MIA-associated abnormalities. We also show that small intestine dendritic cells from pregnant, but not from non-pregnant, females secrete IL-1β, IL-23 and IL-6 and stimulate T cells to produce IL-17a upon exposure to MIA. Overall, our data suggest that defined gut commensal bacteria with a propensity to induce T H 17 cells may increase the risk of neurodevelopmental disorders in the offspring of pregnant mothers undergoing immune system activation owing to infections or autoinflammatory syndromes.
social interaction deficits (decreased interaction with a social stimulus) in adult male offspring (Fig. 1b-d ). These behavioural phenotypes did not emerge from changes in activity or arousal levels as the total investigation time and the total distance travelled during the sociability test remained comparable (Extended Data Fig. 1b, c) . To investigate whether maternal commensal bacteria influence MIA-associated behaviours, we treated wild-type C57BL/6 mice from our vivarium with the broad spectrum antibiotic vancomycin before phosphate-buffered saline (PBS) or poly(I:C) administration (Extended Data Fig. 1d ). Pretreatment of poly(I:C)-injected mothers with vancomycin prevented development of all four behavioural abnormalities in MIA offspring ( Fig. 1a-d) .
We previously showed that MIA offspring exhibit cortical patches devoid of cortical-layer-specific markers, such as SATB2 (ref. 8) , and these cortical patches resemble lesions described in brains of patients with autism spectrum disorder 11, 12 . These cortical patches are predominantly localized in the area encompassing the dysgranular zone of the primary somatosensory cortex and are closely associated with MIA-associated behavioural abnormalities 30 . Unlike the adult offspring derived from poly(I:C)-injected dams, the offspring of poly(I:C)-injected mothers pre-treated with vancomycin failed to develop cortical patches (Fig. 1e, Extended Data Fig. 1e, f) . Vancomycin treatment of poly(I:C)-injected pregnant dams led to a decrease in the proportion of T H 17 cells in the small intestine with a concomitant reduction in the levels of IL-17a in the maternal plasma compared to those of the control group (Fig. 1f, Extended Data Fig. 1g ). These data indicate that the presence in pregnant mice of commensal bacteria that are sensitive to vancomycin is crucial for the induction of MIA-associated behavioural and brain abnormalities in the offspring. Furthermore, the presence of such bacteria is associated with increased proportion of T H 17 cells in the small intestine and high levels of IL-17a in the plasma of poly(I:C)-treated pregnant dams.
Among commensal bacteria in laboratory mice, segmented filamentous bacteria (SFB) are susceptible to vancomycin 13 and contribute disproportionately to T H 17 cell biogenesis in the small intestine 14 . Indeed, qPCR analyses of mouse faecal samples showed that intestinal colonization by SFB is severely reduced upon vancomycin treatment (Extended Data Fig. 1h ). We also performed scanning electron microscopy to visualize SFB associated with intestinal epithelial cells 14 . Although SFB were found attached to the ileal mucosa of the PBStreated dams, SFB associated with intestinal epithelial cells were not detected in the vancomycin-treated dams (Extended Data Fig. 1i ). We therefore next investigated whether the presence of SFB in pregnant mice correlated with the MIA-associated behavioural phenotypes in
Letter reSeArCH
offspring. C57BL/6 mice from Taconic Biosciences (Tac) have abundant T H 17 cells in their small intestine owing to the presence of SFB; in contrast, C57BL/6 mice from Jackson Laboratories (Jax), which lack SFB, have few intestinal T H 17 cells 13, 14 . Unlike offspring from poly(I:C)-injected Tac mothers, those from poly(I:C)-injected Jax mothers did not show any of the MIA-associated behavioural phenotypes ( Fig. 2a-d , Extended Data Fig. 2a, b) . Poly(I:C)-treated Tac and Jax mothers had litters of similar sizes and the pups had similar weights (Extended Data Fig. 2c, d ). Sizes of the cortical patches observed in the offspring of poly(I:C)-injected Tac mothers were highly correlated with the severity of the MIA-associated behavioural abnormalities 30 . Consistent with this finding, MIA offspring from the SFB-deficient Jax mothers injected with poly(I:C) had no cortical abnormalities, as assessed by SATB2 staining (Fig. 2e, Extended Data Fig. 2e, f) . Unlike in Tac mice, Jax mothers injected with poly(I:C) did not show systemic increases in IL-17a in the plasma (Fig. 2f) . However, poly(I:C) injection of both Tac and Jax animals resulted in the robust induction of TNFα and IFNβ, compared to PBS-injected control mice (Extended Data  Fig. 2g ).
Offspring of poly(I:C)-injected Jax mothers that had been either co-housed with Tac mice or gavaged with a faecal slurry from SFB mono-colonized mice (Extended Data Fig. 3a ) displayed MIAassociated behavioural and cortical abnormalities ( Fig. 2a-e) . These MIA-associated phenotypes in the offspring from both the co-housed and SFB-gavaged Jax mothers were accompanied by an increased proportion of gut-residing T H 17 cells, consistent with the presence of SFB in the small intestines of these mice (Extended Data Fig. 3b-d) . Accordingly, the co-housed and SFB-gavaged Jax mothers exhi bited increased levels of plasma IL-17a following poly(I:C) injections (Fig. 2f ) . Thus, the presence or absence of a single commensal bacterial species SFB in the intestines of pregnant mothers influences long-lasting behavioural and neurodevelopmental outcomes in the offspring exposed to MIA.
We next investigated whether maternal exposure to poly(I:C)-induced inflammation or maternal colonization with SFB influence MIA-associated behaviours in offspring after birth. We performed cross-fostering experiments by switching newborns between PBSand poly(I:C)-treated Tac mothers or between SFB-positive Tac and SFB-negative Jax mothers (Extended Data Figs 4a, 5a). Whereas offspring derived from poly(I:C)-injected mothers, but reared by PBSinjected mothers, exhibited behavioural abnormalities, those from PBS-injected mothers that were reared by poly(I:C) mothers exhibited normal behaviours (Extended Data Fig. 4b-g ). Likewise, offspring derived from poly(I:C)-injected Tac mothers, but reared by Jax mice, exhibited behavioural abnormalities, whereas those derived from poly(I:C)-injected Jax mothers and reared by Tac mothers displayed normal behaviours (Extended Data Fig. 5b-g ). These data indicate ; n = 12, 16 (vancomycin; PBS, poly(I:C)); 3-4 independent experiments). e, Representative images of adult offspring brains from PBS-, poly(I:C)-injected mothers treated with vehicle or vancomycin. Arrowheads indicate cortical patch. Scale bar, 100 μm (n = 3, 4 (PBS; vehicle, vancomycin); n = 5, 4 (poly(I:C); vehicle, vancomycin); 2 independent experiments). f, Maternal plasma concentrations of IL-17a 48 h after PBS, poly(I:C) administration into dams at E12.5 (n = 6 per group; 3 independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 calculated by one-way (a-c) and two-way (d) ANOVA with Tukey post hoc tests and Student's t-test (f). NS, not significant. Graphs indicate mean ± s.e.m. ; n = 29, 27 (Jax; PBS, poly(I:C)); n = 29, 29 (co-housed Jax; PBS, poly(I:C)); n = 33, 30 (SFB-gavaged Jax; PBS, poly(I:C)); 7-8 independent experiments). e, Representative images of adult offspring brains from PBS-, poly(I:C)-injected mothers (n = 3, 3 (PBS; Tac, Jax); n = 3, 3 (PBS; co-housed Jax, SFB-gavaged Jax); n = 4, 3 (poly(I:C); Tac, Jax); n = 3, 3 (poly(I:C); cohoused Jax, SFB-gavaged Jax)). Arrowheads indicate cortical patches. Scale bar, 100 μm. f, Maternal plasma concentrations of IL-17a 48 h after administration of PBS, poly(I:C) into dams at E12.5 (n = 6 per group; 2 independent experiments). ***P < 0.001, ****P < 0.0001 calculated by one-way (a-c) and two-way (d) ANOVA with Tukey post hoc tests and Student's t-test (f). NS, not significant. Graphs indicate mean ± s.e.m.
that both the presence of SFB in the small intestines of mothers and the immunological effects of poly(I:C) are critical during pregnancy, not during post-natal nursing, for licensing MIA-induced behavioural abnormalities in offspring.
MIA leads to an increase in plasma IL-17a levels in pregnant mice as early as 12-24 h following E12.5 poly(I:C) injection 8 . Such a rapid increase strongly suggested that pre-existing T H 17 cells, rather than de novo differentiating T H 17 cells, are the major source for IL-17a in pregnant mice exposed to inflammation. As T H 17 cells are most abundant in the small intestine lamina propria, we next investigated whether poly(I:C) stimulates IL-17a production via gut-residing T H 17 cells. In poly(I:C)-treated pregnant mice, T cells isolated from lamina propria, but not spleens or mesenteric lymph nodes, expressed high levels of IL-17a and had increased RORγt expression compared to cells from PBS-treated mice (Extended Data Fig. 6a-f) . Consistent with these observations, ileum-associated mononuclear cells, isolated from poly(I:C)-injected Tac pregnant mice and further stimulated in vitro with poly(I:C), produced higher levels of IL-17a compared to those from PBS-treated Tac mice (Fig. 3, Extended Data Fig. 6g ). In contrast, mononuclear cells from poly(I:C)-treated Jax mice secreted only small amounts of IL-17a (Fig. 3a) . Introduction of SFB into Jax mice either by co-housing them with Tac mice or by gavage with an SFB-containing faecal slurry was sufficient to enable ileum-associated mononuclear cells to produce high levels of IL-17a (Fig. 3a) . To examine which cells are involved in the poly(I:C) response, we separately isolated CD4
+ and non-CD4 + cells from PBS-and poly(I:C)-treated pregnant Tac mice and co-cultured the isolated cells from each experimental group. The CD4 − fraction derived from the poly(I:C)-treated, but not from the PBS-treated, mothers promoted IL-17a production when added to cultures containing CD4
+ cells from either PBS-or poly(I:C)-treated pregnant mice (Extended Data Fig. 6h ). We next tested whether poly(I:C)-primed CD11c
+ dendritic cells (DCs)
were capable of stimulating CD4 + T cells to produce IL-17a. Adding CD11c + DCs derived from poly(I:C)-treated, but not from PBStreated, pregnant mice to ex vivo cultures containing ileal CD4 + T cells that were isolated from either PBS-or poly(I:C)-treated pregnant Tac mice led to robust expression of IL-17a (Fig. 3b ). In contrast, neither splenic CD4 + T cells of poly(I:C)-injected pregnant Tac mice nor ileal CD4 + T cells of poly(I:C)-injected pregnant Jax mice produced IL-17a, even with the help of CD11c + DCs (Fig. 3b) . Thus, both CD4
+ T cells present in the small intestines of Tac mice and poly(I:C)-activated CD11c + DCs are required for robust IL-17a induction. Among the multiple phenotypes of gut-residing DCs, CD103 + CD11b + CD11c + cells were robust inducers of IL-17a when co-cultured with ileal CD4 + T cells (Extended Data Fig. 6i ), consistent with previous reports 15, 16 . As poly(I:C) activates Toll-like receptor 3 (TLR3) 17 , we investigated whether this receptor is involved in stimulation of IL-17a production. Whereas CD4 + T cells, regardless of their Tlr3 genotype, produced IL-17a when mixed with wild-type CD11c + DCs, they failed to do so when co-cultured with TLR3-deficient CD11c + DCs (Fig. 3c) . In addition, poly(I:C) injection of TLR3-KO pregnant mice failed to induce MIA-associated USV phenotypes in offspring (Extended Data Fig. 6j ). These data suggest that MIA-associated phenotypes require functional TLR3 expression on CD11c + DCs. Inflammatory cytokines such as IL-1β, IL-6, and IL-23 enhance the function and differentiation of T H 17 cells 18 . Consistent with this, co-cultures of sorted CD4
+ and CD11c + DCs that were isolated from the ilea of poly(I:C)-treated pregnant Tac mice and incubated with IL-1β-, IL-6-, and IL-23-blocking antibodies failed to produce IL-17a, even when supplemented with poly(I:C) (Fig. 3d) . In contrast, GFP + T H 17 cells, but not GFP − non-T H 17 cells, sorted from the ilea of IL-17a-GFP reporter mice produced high levels of IL-17a in the presence of exogenous IL-1β, IL-6, and IL-23, even in the absence of + T cells. All cultured cells were isolated at E14.5 and stimulated with poly(I:C) for 18 h (a-c, g) or for 48 h (d, e). f, Maternal plasma concentrations of IL-17a 48 h after administration of PBS or poly(I:C) into non-pregnant females or dams at E12.5 (n = 4, 5 (non-pregnant females; PBS, poly(I:C)); n = 4, 5 (pregnant females; PBS, poly(I:C))). All data pooled from 2 independent experiments. **P < 0.01, ****P < 0.0001 calculated by one-way (a-f) ANOVA with Tukey post hoc tests and Student's t-test (g). NS, not significant. Graphs indicate mean ± s.e.m.
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+ DCs (Fig. 3e) . Collectively, these data indicate that poly(I:C) treatment leads to the activation of gut-residing CD103
+ cells, which stimulate poised T H 17 cells to produce IL-17a through secretion of IL-1β, IL-6, and IL-23.
Intriguingly, we noted that poly(I:C) injection of non-pregnant females failed to increase the levels of plasma IL-17a (Fig. 3f ).
Co-culture of ileal CD4
+ and CD11c + DCs isolated from poly(I:C)-treated pregnant females, but not from poly(I:C)-treated non-pregnant females, resulted in secretion of IL-17a ex vivo (Fig. 3g) . Consistent with these findings, gut CD11c + DCs isolated from poly(I:C)-treated pregnant females, but not from poly(I:C)-treated non-pregnant females, produced increased levels of IL-1β, IL-6, and IL-23 (Extended Data  Fig. 6k ). Together, these data collectively suggest that T H 17-cellinducing gut bacteria, a pro-inflammatory stimulus, and pregnancy are all required for the systemic increase in IL-17a in maternal plasma, and this increase in IL-17a promotes MIA-associated behavioural and neurodevelopmental abnormalities in offspring.
We next investigated whether commensal-antigen-specific T H 17 cells in pregnant mothers were sufficient to induce MIA-associated phenotypes in the offspring. Congenically marked naive CD45.1
+ T cells from mice expressing a transgenic T cell receptor (TCR) specific for a SFB-encoded antigen (7B8-Tg) 19 were adoptively transferred into SFB-colonized CD45.2 + recipient mice lacking αβ T cells (TCRα-KO) or deficient in IL-17a production (IL-17a-KO) (Extended Data Fig. 7a ). In line with our previous findings that T H 17 cells are critical mediators of MIA 8 , offspring derived from poly(I:C)-injected TCRα-KO mothers crossed with wild-type C57BL/6 fathers failed to exhibit MIA-induced behavioural phenotypes. On the other hand, offspring from TCRα KO pregnant mothers that had received naive 7B8-Tg CD4 + T cells exhibited MIA-associated behavioural phenotypes even in the absence of exposure to poly(I:C)-induced inflammation (Extended Data Fig. 7b ). We subsequently tested whether IL-17a produced by the SFB antigen-specific CD4 + T cells was sufficient to induce MIA phenotypes in offspring by transferring these cells into IL-17a-KO females 20 . Unlike the offspring from the poly(I:C)-treated IL-17a-KO mothers that had been crossed with wild-type C57BL/6 fathers, offspring of poly(I:C)-injected IL-17a-KO mothers that had received 7B8-Tg CD4
+ T cells displayed all four MIA-associated behavioural abnormalities (Extended Data Fig. 7c ). In addition, offspring from 7B8-Tg CD4 + T cell recipient females exhibited the cortical phenotype (Extended Data Fig. 7d-h) . Induction of the MIA behavi oural phenotypes was accompanied by an increase in IL-17a in the maternal plasma (Extended Data Fig. 7i, j) and increased IL-17a production from SFB-specific donor CD45.1 + T cells, but not from CD45.2 + T cells of IL-17a-KO recipient mice (Extended Data Fig. 7k ). Therefore, these results indicate that microbiota-specific gut T H 17 cells present in pregnant mice are sufficient to produce abnormal behavioural and neurodevelopmental phenotypes in the offspring when accompanied by strong signalling for IL-17a production in the mother.
Finally, we investigated whether gut-residing bacteria isolated from humans could also promote MIA-associated phenotypes in mice. Administration of a mix of twenty different commensal bacteria isolated from human faecal samples was previously shown to induce T H 17 cells in the large intestines of mice 21 . We orally gavaged Jax mothers with a mix of these twenty human bacterial strains twice, on E3.5 and E10.5, followed by a poly(I:C) injection at E12.5 (Extended Data Fig. 8a) . Introduction of the twenty strains led to stable colonization of 2-10 commensal bacteria (Supplementaty Table 1 ) and, as previously shown 21 , to an increased percentage of T H 17 cells in the colons of the recipient mice (Extended Data Fig. 8b) . Unlike in the SFB-colonized Jax mice, we could not detect SFB in the ilea of the reci pient mice (Extended Data Fig. 8c ). Importantly, poly(I:C) injection of the human-bacteria-gavaged Jax mice induced high levels of IL-17a in the maternal plasma and MIA-associated abnormal behavioural and nerurodevelopmental phenotypes in the offspring (Fig. 4 , Extended Data Fig. 8d-g ). These MIA-associated phenotypes were not observed if the mothers were pre-treated with IL-17a-blocking antibody (Fig. 4, Extended Data Fig. 8d-g ).
There have been several recent reports of individual human commensal bacteria that promote differentiation of intestinal T H 17 cells 22, 23 . Unlike offspring from Jax mothers colonized with Listeria monocytogenes or Bacteroides fragilis, in which there is no induction of T H 17 cells, offspring of mice colonized with T H 17-cell-inducing Bifidobacterium adolescentis or an adherent Escherichia coli isolate, CD-SpA 2A, emitted enhanced USV calls (Extended Data Fig. 9a-c) . The presence of MIA-associated behavioural phenotypes in offspring correlated with increased IL-17a in the plasma of poly(I:C)-injected mothers (Extended Data Fig. 9d ). On the other hand, pregnant mice gavaged with L. monocytogenes had increased IFNγ production (Extended Data Fig. 9e ). None of these human-bacteria-gavaged mothers were colonized with SFB (Extended Data Fig. 9f ). Thus, intestinal T H 17 cell induction by individual human commensal bacteria contributes to the development of MIA-associated abnormality in mouse offspring.
Accumulating evidence suggests that the gut commensal microbiota have roles in autoimmune diseases and cancer [24] [25] [26] . Moreover, intricate relationships exist between the bacterial community in the gastrointestinal tract and the central nervous system [27] [28] [29] . Our findings extend our understanding of the potential of microbiota to influence the likelihood of a mother having offspring with neurodevelopmental disorders. Women with gut microbial communities that promote excessive T H 17 cell differentiation may therefore be more likely to bear children with autistic spectrum disorder in the event of pathological inflammation during pregnancy. A better understanding of the role of the maternal microbiota and pregnancy-associated changes in gut-residing immune 
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Maternal immune activation.
Mice were mated overnight and females were checked daily for the presence of seminal plugs, noted as embryonic day 0.5. On E12.5, pregnant female mice were weighed and injected with a single dose (20 mg kg −1 ; i.p.) of poly(I:C) (Sigma Aldrich) or PBS vehicle. Each dam was returned to its cage and left undisturbed until the birth of its litter. All pups remained with the mother until weaning on postnatal day 21-28 (P21-P28), at which time mice were group housed at a maximum of 5 per cage with same-sex littermates. Co-housing, SFB-gavaged and antibiotics-gavaged mice. For co-housing experiments, age-matched SFB-absent mice (from Jackson Laboratory) were co-housed with SFB-present mice (from Taconic Biosciences) in sterilized cages for two weeks at a ratio of 2:3, with unrestricted access to food and water. For SFB-gavaging experiments, four faecal pellets of SFB mono-colonized mice (provided by D.R.L.) were dissolved in 20 ml sterile PBS and filtered though a 100-μm cell strainer. 200 μl of faecal suspensions were gavaged via oral route to 4-week-old female Jackson mice. Control mice were gavaged with PBS. The SFB colonization was tested on day 7 following co-housing or SFB-gavaging. For ablation of intestinal bacteria, Taconic-derived female mice were orally gavaged with vancomycin hydrochloride (Fisher) (2.5 mg kg ). Colonization levels were determined by collecting mouse faecal samples at E12.5, re-suspending them with PBS and subsequently plating on BHI agar. Cross-fostering. The day on which pups were born was considered P0. Pups were cross-fostered between P0 and P1. Whole litters were removed from the original mothers. Pups were gently mixed with the bedding of the new cage. Pups were then introduced to the new cage with a foster mother. Pups from PBS-and poly(I:C)-treated Taconic mothers were cross-fostered to poly(I:C)-and PBS-treated Taconic mothers, respectively. Additionally, pups from Taconic-and Jax-derived mothers were cross-fostered to a Jax-and Taconic-derived dam, respectively. Behavioural assays. All behavioural testing were carried out according to the previously established behavioural schemes 8 with minor modifications. Blinding was performed for all the behavioural experiments except for the experiments with human bacteria. Ultrasonic vocalizations. On P9, both male and female offspring mice were removed from the nest and habituated to the testing room for 30 min. After the habituation period, mouse pups were placed in a clean 15-cm glass Pyrex high wall dish. Ultrasonic vocalizations (USVs) were detected for 3 min using an UltraSoundGateCM16/CMPA microphone (AviSoft) in the sound attenuation chamber under stable temperature and light control, and recorded with SAS Prolab software (AviSoft). USVs were measured between 33-125 kHz using Ultravox software (Noldus Information Technology, USA). Owing to the unreliability of automated USV scoring, all pup USV calls were counted manually and plotted on the y axis. As both male and female pups of poly(I:C)-injected mothers emitted comparable levels of USVs (Extended Data Fig. 1a) , we did not separately analyse male versus female USV phenotypes. Both sexes were used for the experiments. Three-chamber social approach. 8-12-week-old male mice were tested for social behaviour using the three-chamber social approach paradigm. Experimental mice were habituated for 1 h in separate clean holding cages and then introduced into a three-chamber arena with only empty object-containment cages (circular metallic cages, Stoelting Neuroscience) for a total 10-min acclimation phase in two 5-min sessions. The following day, the mice were placed in the centre chamber (without access to the left and right social test areas) and allowed to explore the centre area for 5 min. After this exploration period, barriers to adjacent chambers were removed, allowing mice to explore the left and right arenas, which contained a social object (unfamiliar C57BL/6 male mouse) in one chamber and an inanimate object (black rubber stopper) in the other chamber. Experimental mice were given 10 min to explore both chambers and measured for approach behaviour as interaction time (that is, sniffing, approach) with targets in each chamber (within 2 cm). Sessions were video-recorded and object exploration time and total distance moved were analysed using the Noldus tracking system. Percentage interaction was calculated as the percentage of time spent investigating the social stimulus out of the total exploration time of both objects (Supplementary Table 2 ) and plotted on the y axis. Arenas and contents were thoroughly cleaned between testing sessions. Multiple social targets from different home cages were used for testing to prevent potential odorant confounds from target home cages. Marble burying test. Male mice were placed in a testing arena (arena size: 40 × 20 cm 2 , bedding depth: 3 cm) containing 20 glass marbles, which were laid out in four rows of five marbles equidistant from one another. At the end of a 15 min exploration period, mice were gently removed from the testing cages and the number of marbles buried was recorded. A marble burying index was scored as 1 for marbles covered >50% by bedding, 0.5 for around 50% covered, or 0 for anything less. Percentage of buried marbles is plotted on the y axis. Open field test. Mice underwent a 15-min exploration period in the testing arena (arena size: 50 × 50 cm 2 ). Sessions were video-recorded and analysed for time spent in the centre (centre size: 25 × 25 cm 2 ) using EthoVision Noldus tracking system (Noldus). Time spent in the centre of an open field is plotted on the y axis. Immunohistochemistry. Adult male mice were perfused and fixed with 4% paraformaldehyde in PBS overnight at 4 °C. The brains were removed and sectioned at 50 μm thickness with a Leica VT100S vibratome (Leica). Slices were permeabilized with blocking solution containing 0.4% Triton X-100, 2% goat serum, and 1% BSA in PBS for 1 h at room temperature, and then incubated with anti-SATB2 (special AT-rich sequence-binding protein 2) (ab51502, Abcam) antibodies overnight at 4 °C. The following day, slices were incubated with fluorescently conjugated secondary antibodies (Invitrogen) for 1 h at room temperature, and mounted in Vectashield mounting medium with DAPI (Vector Laboratories). Images of stained brain slices were acquired using a confocal microscope (LSM710. Carl Zeiss) with a 20× objective lens. The cortical malformation images were analysed using ImageJ software. The images were cropped to have S1 cortical patches in the centre. Analysis of cortical patches. Cortical patches were identified as cortical regions devoid of SATB2 expression. The size of the cortical patches in the S1 was calculated using Zen software (Carl Zeiss). The cortical region was divided into 10 equal laminar blocks representing different depths of the cortex. SATB2 positive cells were quantified manually. Scanning electron microscopy. Terminal ileum tissues from mice (12-14 weeks old) were cut open and fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight and processed for standard scanning electron microscopy at the EM centre, University of Massachusetts Medical School. All samples were analysed on a Hitachi S-4800 Type II Field Emission Scanning Electron Microscope. 16S rRNA quantitative PCR analysis. Bacterial genomic DNA was isolated from the faecal pellets of mice with phenol-chloroform extraction. qPCR was performed to quantify relative abundance of SFB, human commensal bacteria or total bacteria using group specific 16S rDNA primers (Supplementaty Table 3 ). Undetected qPCR values from non-colonized samples were replaced with a C t value of 40 for the purpose of comparison. Lamina propria mononuclear cell preparation. For mononuclear cell isolations, both mesenteric fat tissues and Peyer's patches were carefully removed Letter reSeArCH from intestinal tissues. Terminal ileal or colonic tissues were incubated in 5 mM EDTA in PBS containing 1 mM DTT at 37 °C on a shaker (200 r.p.m.) for 20 min. Tissues were washed one more time. Tissues were then further digested for 30 min at 37 °C in RPMI containing 10% fetal bovine serum, 1.0 mg ml −1 collagenase D (Roche) and 100 μg ml −1 DNase I (Sigma). Digested tissues were then filtered using a 100 μm cell strainer and incubated for additional 10 min at 37 °C. Mononuclear cells were isolated from an interphase of percoll gradients (40:80 gradient). Flow cytometry. Mononuclear cells were incubated with or without 50 ng ml −1 phorbol myristate acetate (PMA) (Sigma) and 500 ng ml −1 ionomycin (Sigma) in the presence of GolgiStop (BD) in complete T cell media at 37 °C for 5 h. Intracellular cytokine staining was performed according to the manufacturer's protocol. Cells were stained with Pacific-Blue-conjugated anti-CD4 (RM-5), PerCP-Cy5.5-conjugated anti-CD8a (53-6.7), APC-Cy7-conjugated anti-TCRβ (H57-597), FITC-conjugated anti-CD62L (MEL-14), APC-conjugated anti-CD44 (IM7), PE-conjugated-CD25 (PC61.5), PerCP-Cy5.5-conjugated-CD19 (eBio1D3), APC-conjugated anti-CD45.1 (A20), FITC-conjugated anti-CD45.2 (104), PacificBlue-conjugated anti-CD11c (N418), FITC-conjugated-anti-CD11b (M1/70), PerCP-Cy5.5-conjugated-anti-CD103 (2E7) (eBioscience), Biotin-conjugated Vβ14 (14-2) (BD phamigen) and PE-Cy7-conjugated-Streptavidin (Thermo Fisher Scientific). Cells were further stained intracellularly with APC-conjugated anti-RORγ (B2D) (eBioscience) and PE-Cy7-conjugated anti-IL-17a (eBio17B7) (eBioscience) using Foxp3 staining/permeabilization buffer (eBioscience). Flow cytometric analysis was performed on an LSRII (BD Biosciences). All data were re-analysed using FlowJo (Tree Star). Adoptive transfer. Spleen and lymph nodes from 7B8-Tg mice were collected and disassociated. Red blood cells were lysed using ACK lysis buffer (Lonza). Naive ) (R&D System). All cells were cultured in T cell media: RPMI 1640 (Invitrogen) supplemented with 10% (v/v) heat-inactivated FBS (Hyclone) and 50 U penicillin-streptomycin (Invitrogen). Cell culture supernatant was used for ELISA analyses. ELISA. IL-17a, TNFα, IFNβ, IL-1β and IL-23 levels were measured according to the manufacturer's protocol (BioLegend). IL-6 and IFNγ levels were measured according to the manufacturer's protocol (eBioscience). Statistics. Statistical analyses were performed using GraphPad Prism. ANOVAs were followed by Tukey or Sidak tests. All data are represented as mean ± s.e.m. Sample sizes were determined on the basis of similarly conducted studies 8 . When conducting behavioural assays, cages were pseudo-randomly assigned for tests. Detailed statistical analyses for behavioural assays are included in the Supplementary Information. Data availability. Source Data are available in the online version of the paper. All other data are available from the corresponding author upon reasonable request. + cells (e) in the cortex divided into ten equal bins representing different depths of the cortex or of the cortical patch size (f) in the primary somatosensory cortex (S1) (n = 3, 4 (PBS; vehicle, vancomycin); n = 3, 4 (poly(I:C); vehicle, vancomycin); 2 independent experiments).
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g, Flow cytometry of CD4
+ T cells (gated on TCRβ + CD4 + ) stained intracellularly for IL-17a and RORγt. Mononuclear cells were collected at E14.5 from the ilea of poly(I:C)-treated mice with/without vancomycin treatment; representative FACS plot from 3 independent experiments. h, qPCR analysis measuring relative SFB levels in C57BL/6 mice before/ after vancomycin treatments (n = 4-5 per group). i, Representative s.e.m. images of epithelial surfaces in the ilea of the vehicle-/vancomycin-treated mice from 2 independent experiments. Scale bars, 30 μm. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 calculated by two-way (a, e) and one-way (b, c, f) ANOVA with Tukey post hoc tests. NS, not significant. Graphs indicate mean ± s.e.m. Figure 2 | MIA in SFB-absent Jax mothers does not induce changes in the total activity of the adult offspring, properties of the litter and maternal cytokine production. a, b, Total investigation time (a) and total distance travelled (b) during the sociability test of adult offspring described in Fig. 2b-d . c, Litter size upon weaning (n = 59, 125 (Tac; PBS, poly(I:C)); n = 51, 50 (Jax; PBS, poly(I:C)); n = 55, 81 (cohoused Jax; PBS, poly(I:C)); n = 55, 89 (SFB-gavaged Jax; PBS, poly(I:C)). d, Weight of male offspring from the groups described in c (n = 32, 50 (Tac; PBS, poly(I:C)); n = 29, 27 (Jax; PBS, poly(I:C)); n = 29, 29 (co-housed Jax; PBS, poly(I:C)); n = 33, 30 (SFB-gavaged Jax; PBS, poly(I:C)). Data in c and d are from 7-8 independent experiments. e, f, Quantification of SATB2 + cells (e) in the cortex divided into ten equal bins representing different depth and of patch size (f) in the S1 (n = 4 (Tac; PBS); n = 3, 3, 4, 3 (Tac, Jax, co-housed Jax, SFB-gavaged Jax; poly(I:C)). g, Maternal plasma concentrations of TNFα and IFNβ at 3 h after PBS, poly(I:C) injection into Tac/Jax dams at E12.5; n = 4 per group. *P < 0.05, **P < 0.01, ***P < 0.001 calculated by two-way (e) and oneway ANOVA (a-d, f) with Tukey post hoc tests and Student's t-test (g). Graphs indicate mean ± s.e.m.
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Extended Data
Data exclusions
Describe any data exclusions.
We have not excluded any data.
Replication
Describe whether the experimental findings were reliably reproduced. Experimental findings were reliably reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Subject animals were randomly assigned to experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was done for all the behavioral experiments except for the experiments with human bacteria (Material & Methods, p45).
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
GraphPad Prism 6
June 2017
For all studies, we encourage code deposition in a community repository (e.g. GitHub). Authors must make computer code available to editors and reviewers upon request. The Nature Methods guidance for providing algorithms and software for publication may be useful for any submission.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No unique material was used.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Pacific Blueconjugated anti-CD4 (RM-5), PerCP-Cy5.5-conjugated antiCD8a (53-6.7), APC-Cy7-conjugated anti-TCRβ (H57-597), FITC-conjugated anti-CD62L (MEL-14), APCconjugated anti-CD44 (IM7), PE-conjugated-CD25 (PC61.5), PerCP-Cy5.5-conjugated-CD19 (eBio1D3), APC-conjugated anti-CD45.1 (A20), FITC-conjugated anti-CD45.2(104), Pacific Blue conjugated anti-CD11c (N418), FITC conjugated-anti-CD11b (M1/70), PerCP-Cy5.5-conjugated-anti-CD103 (2E7) (eBioscience), Biotin-conjugated Vβ14 (14-2) (BD phamigen) and PE-Cy7-conjugated-Streptavidin (Thermo Fisher Scientific). Cells were further stained intracellularly with APCconjugated anti-RORγ (B2D) (eBioscience) and PE-Cy7-conjugated anti-IL-17a (eBio17B7) (eBioscience) 
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
All experiments were performed according to Guide for the Care and Use of Laboratory Animals and were approved by the National Institutes of Health and the Committee and Animal Care at University of Massachusetts Medical School. C57BL/6, tcra KO, tlr3 KO, il17a gfp and SFB-specific TCR Tg (7B8) mice were purchased from Taconic biosciences and Jackson Laboratory. To induce MIA phenotypes, SFB were introduced into mice purchased from Jackson laboratory. Il17aKO mice were described elsewhere (ref. 25) Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
The study did not involve human research participants.
